Fny Investment Advisers, LLC Clovis Oncology, Inc. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$0.63 - $2.96 $630 - $2,960	-1,000 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$1.43 - $3.14 $1,430 - $3,140	1,000 New	1,000 $2,000
Q1 2021 Apr 12, 2021	SELL	$4.81 - $10.34 $480 - $1,034	-100 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$4.82 - $7.72 $5,784 - $9,264	-1,200 Reduced 92.31%	100 $0
Q2 2020 Jul 10, 2020	BUY	$5.69 - $9.69 $7,397 - $12,597	1,300 New	1,300 $8,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.